This inventor holds 6 USPTO granted patents. Top assignees: Sumitomo Pharmaceuticals Company Limited, Sumitomo Chemical Company, Limited. Active years: 1985-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (1988)
- Ibaraki, JP (1989)
- Osaka, JP (1985 - 1992)
Company Filing History:
Years Active: 1985-1992
Title: Masao Enomoto: Innovator in Pharmaceutical Chemistry
Introduction
Masao Enomoto is a distinguished inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on thiazolidin-4-one derivatives. With a total of six patents to his name, Enomoto's inventions have the potential to impact medical treatments significantly.
Latest Patents
Enomoto's latest patents include thiazolidin-4-one derivatives and their acid addition salts, which are useful for various therapeutic applications. One notable patent describes a thiazolidin-4-one derivative represented by a specific general formula, where R1 and R2 can denote various chemical groups. Another significant invention is a 2-pyridyl-thiazolidin-4-one derivative, which has demonstrated anti-ulcer activity. This derivative can include a range of substituents, making it versatile for pharmaceutical applications.
Career Highlights
Throughout his career, Masao Enomoto has worked with prominent companies such as Sumitomo Pharmaceuticals Company Limited and Sumitomo Chemical Company, Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical chemistry.
Collaborations
Enomoto has collaborated with notable colleagues, including Atsuyuki Kojima and Yoshihiro Komuro. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Masao Enomoto's work in pharmaceutical chemistry exemplifies the impact of innovation on medical science. His contributions through patents and collaborations highlight the importance of research and development in creating effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile